The effect of adaptation nurturance on the self-efficacy and quality of life of patients with colorectal cancer undergoing chemotherapy

Comparing the effect of adaptation nurturance using the Adaptive Potential Assessment Model (APAM) and routine education praogram on the self-efficacy and quality of life of patients with colorectal cancer undergoing chemotherapy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150607022592N3

Enrollment

Registered

2023-11-06

Start date

2023-11-08

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer. Malignant neoplasms of digestive organs: Malignant neoplasm of colon, Malignant neoplasm of rectosigmoid junction, Malignant neoplasm of rectum, Malignant neoplasm of anus and anal canal

Interventions

Intervention 1: Intervention group: The intervention begins in the second phase of chemotherapy after obtaining informed consent. First, questionnaires to check demographic information, self-efficac

Eligibility

Sex/Gender

All

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Being at the age of 30-80 years old Having Colorectal cancer with an oncologist special diagnosis Having a caregiver at home Being Persian Having the ability to speak Having a personal smart phone

Exclusion criteria

Exclusion criteria: Reducing level of consciousness and being refereed to ICU Evidence of metastasis in the description of the patient's operation Having a diagnosed psychological disease

Design outcomes

Primary

Measure	Time frame
Self-efficacy score. Timepoint: Before the intervention - the first month and the second month after the start of the study. Method of measurement: Cancer Behavior Inventory–Brief Version (CBI-B).;Quality of life score. Timepoint: Before the intervention; 1 month and 2 months later. Method of measurement: Quality of life questionnaire-cancer 30 (EORTC QLQ-C30).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Aghebati

Mashhad University of Medical Sciences

aghebatin@mums.ac.ir+98 51 3800 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026